Northern Trust Corp Plus Therapeutics, Inc. Transaction History

Northern Trust Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.27 - $0.48 $6,882 - $12,236	25,492 Added 79.44%	57,581 $16,000
Q3 2021 Nov 15, 2021	SELL	$1.83 - $2.46 $15,436 - $20,750	-8,435 Reduced 20.81%	32,089 $61,000
Q2 2021 Aug 13, 2021	BUY	$2.0 - $2.89 $81,048 - $117,114	40,524 New	40,524 $104,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $51.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.